Incyte Corp.

INCY ·Healthcare, Diagnostics & Research, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Revenue $1.54B $1.11B $753.8M $511.5M $354.7M $297.1M $95.1M $169.9M
Jakafi Net Product Revenues $1.16B $852.6M $357.6M $235.4M $2.0M
Other Net Product Revenues $68.3M $38.6M $0 $0 $0
Royalty Revenues $204.0M $144.4M $68.9M $39.3M $0
Milestone and Contract Revenues $105.0M $70.0M $85.0M $80.0M $93.1M
Cost of Revenue $79.5M $58.2M $27.0M $3.0M $630.0K $157.0K
Gross Profit $1.46B $1.05B $726.8M $508.5M $354.1M $296.9M
Gross Margin 94.8% 94.7% 96.4% 99.4% 99.8% 99.9%
Operating Expenses
Research & Development $1.33B $581.9M $479.5M $347.5M $260.4M $210.4M $178.7M $123.9M
SG&A Expense $366.3M $303.3M $196.6M $165.8M $110.0M $85.4M $58.2M $32.3M
Operating Income $-243.4M $145.0M $50.7M $-4.8M $-16.1M $1.1M $-143.2M $14.0M
Operating Margin -15.9% 13.1% 6.7% -0.9% -4.5% 0.4% -150.5% 8.3%
Interest Expense $6.9M $38.7M $45.6M $46.8M $38.7M $46.1M $43.8M $43.3M
Pretax Income $-312.3M $107.4M $7.6M $-48.5M $-82.8M $-44.1M $-186.5M $-31.8M
Income Tax Expense $852.0K $3.2M $1.0M $-66.0K $299.0K $174.0K
Net Income $-313.1M $104.2M $6.5M $-48.5M $-83.1M $-44.3M $-186.5M $-31.8M
Net Margin -20.4% 9.4% 0.9% -9.5% -23.4% -14.9% -196.1% -18.7%
EPS (Basic) $-1.53 $0.55 $0.04 $-0.29 $-0.56 $-0.34 $-1.49 $-0.26
EPS (Diluted) $-1.53 $0.54 $0.03 $-0.29 $-0.56 $-0.34 $-1.49 $-0.26
Shares Outstanding (Basic) 204.6M 187.9M 179.6M 167.9M 148.4M 133.5M 125.4M 121.6M
Shares Outstanding (Diluted) 204.6M 194.1M 187.3M 167.9M 148.4M 133.5M 125.4M 121.6M
Dividends Per Share
← Newer Page 2 of 3 Older →